Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2000 4
2001 5
2002 3
2003 4
2004 4
2005 3
2006 5
2007 6
2008 2
2009 1
2010 4
2011 5
2012 5
2013 7
2014 3
2015 8
2016 7
2017 6
2018 9
2019 10
2020 10
2021 10
2022 11
2023 9
2024 13
2025 13
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Results by year

Citations

4 articles found by citation matching

Search results

Filters applied: Humans. Clear all
Page 1
Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules.
Lv L, Ruan G, Ping Y, Cheng Y, Tian Y, Xiao Z, Zhao X, Chen D, Wei Y. Lv L, et al. Front Cell Infect Microbiol. 2022 Sep 28;12:1025889. doi: 10.3389/fcimb.2022.1025889. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36250045 Free PMC article.
OBJECTIVE: To study the effect of precision probiotic strains transplantation capsules on diarrhea irritable bowel syndrome compared with fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules. METHODS: …
OBJECTIVE: To study the effect of precision probiotic strains transplantation capsules on diarrhea irritable bowel syndrome compared …
Novel Enterococcus faecium P2 as a probiotic for mitigating Clostridioides difficile infection.
Cui Y, Jia Q, Yan H, Hua X, Tan Y, Jian W, Gong X, Hayer K, Xing S, Zhang Y, Liu J, Wu Y, Yadegar A, Gu T, Tu Z. Cui Y, et al. Microb Pathog. 2025 Nov;208:108028. doi: 10.1016/j.micpath.2025.108028. Epub 2025 Sep 10. Microb Pathog. 2025. PMID: 40934987
In this study, we isolated Enterococcus faecium (E. faecium) P2 from the feces of a healthy child and evaluated its probiotic efficacy against C. difficile infection (CDI) using a mouse model. ...Fecal microbiota analysis revealed that E. faecium
In this study, we isolated Enterococcus faecium (E. faecium) P2 from the feces of a healthy child and evaluated its …
Treatment with a Probiotic Mixture Containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the Prevention of Allergic Rhinitis Symptoms in Children: A Randomized Controlled Trial.
Anania C, Di Marino VP, Olivero F, De Canditiis D, Brindisi G, Iannilli F, De Castro G, Zicari AM, Duse M. Anania C, et al. Nutrients. 2021 Apr 16;13(4):1315. doi: 10.3390/nu13041315. Nutrients. 2021. PMID: 33923532 Free PMC article. Clinical Trial.
The aim of this study is to determine if the prophylactic treatment with a mixture of Bifidobacterium animalis subsp. Lactis BB12 and Enterococcus faecium L3 would reduce symptoms and need for drug use in children with allergic rhinitis (AR). ...Lactis BB12 D …
The aim of this study is to determine if the prophylactic treatment with a mixture of Bifidobacterium animalis subsp. Lactis BB12 and …
Association of Probiotic Treatment With Antibiotics in Male Accessory Gland Infections.
Grande G, Pompa G, Astorri AL, Pontecorvi A, Milardi D. Grande G, et al. Am J Mens Health. 2022 Sep-Oct;16(5):15579883221119064. doi: 10.1177/15579883221119064. Am J Mens Health. 2022. PMID: 36255039 Free PMC article.
All patients received antibiotic treatment with fluoroquinolones. In total, 84 patients received a commercial association of Enterococcus faecium and Saccharomyces boulardii during antibiotic treatment, followed by treatment with Lactobacilli. . …
All patients received antibiotic treatment with fluoroquinolones. In total, 84 patients received a commercial association of Enter
Synergistic activity of Enterococcus Faecium-induced ferroptosis via expansion of IFN-gamma(+)CD8(+) T cell population in advanced hepatocellular carcinoma treated with sorafenib.
Yu H, Lin G, Jiang J, Yao J, Pan Z, Xie H, Bo Z, He Q, Yang J, Chen Z, Li J, Wang Y, Yu Z, Assaraf YG, Chen G. Yu H, et al. Gut Microbes. 2024 Jan-Dec;16(1):2410474. doi: 10.1080/19490976.2024.2410474. Epub 2024 Oct 1. Gut Microbes. 2024. PMID: 39353096 Free PMC article.
The gut microbiota plays an important role in the development and treatment of hepatocellular carcinoma (HCC). However, the implication of specific gut microbiota in targeted sorafenib therapy for advanced HCC and the microbiota mode of action, remain to be elucidat …
The gut microbiota plays an important role in the development and treatment of hepatocellular carcinoma (HCC). However, the implicati …
[The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
Yakovenko EP, Strokova TV, Ivanov AN, Iakovenko AV, Gioeva IZ, Aldiyarova MA. Yakovenko EP, et al. Ter Arkh. 2022 Feb 15;94(2):180-187. doi: 10.26442/00403660.2022.02.201368. Ter Arkh. 2022. PMID: 36286741 Clinical Trial. Russian.
For patients of control group similar therapy was performed without the Bifiform. Evaluation of the effectiveness of treatment was carried out at the end of the course of therapy and 6 months after its termination. ...The majority of patients in the main grou …
For patients of control group similar therapy was performed without the Bifiform. Evaluation of the effectiveness of treatment
[Pathogenicity of Enterococci].
Ike Y. Ike Y. Nihon Saikingaku Zasshi. 2017;72(2):189-211. doi: 10.3412/jsb.72.189. Nihon Saikingaku Zasshi. 2017. PMID: 28659548 Free article. Review. Japanese.
Enterococcus have many favorable traits that have been appreciated in food fermentation and preservation, and many serve as probiotics to promote health. ...The modern life style including the broad use of antibiotics in medical practice and animal husbandry have se
Enterococcus have many favorable traits that have been appreciated in food fermentation and preservation, and many serve as probio
Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin.
Lund B, Adamsson I, Edlund C. Lund B, et al. Int J Food Microbiol. 2002 Jul 25;77(1-2):109-15. doi: 10.1016/s0168-1605(02)00047-8. Int J Food Microbiol. 2002. PMID: 12076027 Clinical Trial.
The primary aim of this study was to evaluate if an ingested probiotic, containing viable Enterococcus faecium could survive gastrointestinal transit and if so, correlate the amount of the recovered probiotic strain with the host's own enterococci. ... …
The primary aim of this study was to evaluate if an ingested probiotic, containing viable Enterococcus faecium could su …
Enterococcus faecium R0026 Combined with Bacillus subtilis R0179 Prevent Obesity-Associated Hyperlipidemia and Modulate Gut Microbiota in C57BL/6 Mice.
Huang J, Huang J, Yin T, Lv H, Zhang P, Li H. Huang J, et al. J Microbiol Biotechnol. 2021 Feb 28;31(2):181-188. doi: 10.4014/jmb.2009.09005. J Microbiol Biotechnol. 2021. PMID: 33144552 Free PMC article.
Bacillus subtilis and Enterococcus faecium are commonly used probiotics. This study aimed to identify the effect of live combined Bacillus subtilis R0179 and Enterococcus faecium R0026 (LCBE) on obesityassociated hyperlipidemia and gut microbiot …
Bacillus subtilis and Enterococcus faecium are commonly used probiotics. This study aimed to identify the effect of liv …
Probiotics: "living drugs".
Elmer GW. Elmer GW. Am J Health Syst Pharm. 2001 Jun 15;58(12):1101-9. doi: 10.1093/ajhp/58.12.1101. Am J Health Syst Pharm. 2001. PMID: 11449853 Review.
The yeast Saccharomyces boulardii and the bacterium Lactobacillus rhamnosus, strain GG, have shown efficacy in clinical trials for the prevention of antimicrobial-associated diarrhea. Other probiotics that have demonstrated at least some promise as prophylaxis for this typ …
The yeast Saccharomyces boulardii and the bacterium Lactobacillus rhamnosus, strain GG, have shown efficacy in clinical trials for the preve …
154 results